209 related articles for article (PubMed ID: 24662455)
1. Membrane carbonic anhydrase IX expression and relapse risk in resected stage I-II non-small-cell lung cancer.
Stewart DJ; Nunez MI; Behrens C; Liu D; Lin YH; Lee JJ; Roth J; Heymach J; Swisher SG; Hong WK; Wistuba II
J Thorac Oncol; 2014 May; 9(5):675-84. PubMed ID: 24662455
[TBL] [Abstract][Full Text] [Related]
2. Carbonic anhydrase IX expression, a novel surrogate marker of tumor hypoxia, is associated with a poor prognosis in non-small-cell lung cancer.
Swinson DE; Jones JL; Richardson D; Wykoff C; Turley H; Pastorek J; Taub N; Harris AL; O'Byrne KJ
J Clin Oncol; 2003 Feb; 21(3):473-82. PubMed ID: 12560438
[TBL] [Abstract][Full Text] [Related]
3. Expression of HIF-1alpha, CA IX, VEGF, and MMP-9 in surgically resected non-small cell lung cancer.
Kim SJ; Rabbani ZN; Dewhirst MW; Vujaskovic Z; Vollmer RT; Schreiber EG; Oosterwijk E; Kelley MJ
Lung Cancer; 2005 Sep; 49(3):325-35. PubMed ID: 15935515
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical detection of HIF-1alpha and CAIX in advanced head-and-neck cancer. Prognostic role and correlation with tumor markers and tumor oxygenation parameters.
Kappler M; Taubert H; Holzhausen HJ; Reddemann R; Rot S; Becker A; Kuhnt T; Dellas K; Dunst J; Vordermark D; Hänsgen G; Bache M
Strahlenther Onkol; 2008 Aug; 184(8):393-9. PubMed ID: 18956515
[TBL] [Abstract][Full Text] [Related]
5. Carbonic anhydrase IX in early-stage non-small cell lung cancer.
Kim SJ; Rabbani ZN; Vollmer RT; Schreiber EG; Oosterwijk E; Dewhirst MW; Vujaskovic Z; Kelley MJ
Clin Cancer Res; 2004 Dec; 10(23):7925-33. PubMed ID: 15585626
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levels.
Bache M; Reddemann R; Said HM; Holzhausen HJ; Taubert H; Becker A; Kuhnt T; Hänsgen G; Dunst J; Vordermark D
Int J Radiat Oncol Biol Phys; 2006 Dec; 66(5):1481-7. PubMed ID: 17056190
[TBL] [Abstract][Full Text] [Related]
7. A pilot study on potential plasma hypoxia markers in the radiotherapy of non-small cell lung cancer. Osteopontin, carbonic anhydrase IX and vascular endothelial growth factor.
Ostheimer C; Bache M; Güttler A; Kotzsch M; Vordermark D
Strahlenther Onkol; 2014 Mar; 190(3):276-82. PubMed ID: 24322994
[TBL] [Abstract][Full Text] [Related]
8. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance.
Brennan DJ; Jirstrom K; Kronblad A; Millikan RC; Landberg G; Duffy MJ; Rydén L; Gallagher WM; O'Brien SL
Clin Cancer Res; 2006 Nov; 12(21):6421-31. PubMed ID: 17085655
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of carbonic anhydrase IX overexpression in stage III non-small cell lung cancer patients after neoadjuvant treatment.
Ibis K; Saglam S; Saglam EK; Firat P; Yilmazbayhan D; Toker A; Ozkan B; Hancer VS; Buyukdogan M; Disci R; Pilanci KN
Pathol Res Pract; 2018 Sep; 214(9):1291-1296. PubMed ID: 30029935
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival.
Hui EP; Chan AT; Pezzella F; Turley H; To KF; Poon TC; Zee B; Mo F; Teo PM; Huang DP; Gatter KC; Johnson PJ; Harris AL
Clin Cancer Res; 2002 Aug; 8(8):2595-604. PubMed ID: 12171890
[TBL] [Abstract][Full Text] [Related]
11. Expression of CA-IX is associated with advanced stage tumors and poor survival in oral squamous cell carcinoma patients.
Pérez-Sayáns M; Suárez-Peñaranda JM; Pilar GD; Supuran CT; Pastorekova S; Barros-Angueira F; Gándara-Rey JM; García-García A
J Oral Pathol Med; 2012 Oct; 41(9):667-74. PubMed ID: 22486898
[TBL] [Abstract][Full Text] [Related]
12. Carbonic anhydrase IX is a marker of hypoxia and correlates with higher Gleason scores and ISUP grading in prostate cancer.
Ambrosio MR; Di Serio C; Danza G; Rocca BJ; Ginori A; Prudovsky I; Marchionni N; Del Vecchio MT; Tarantini F
Diagn Pathol; 2016 May; 11(1):45. PubMed ID: 27225200
[TBL] [Abstract][Full Text] [Related]
13. Carbonic anhydrase IX up-regulation is associated with adverse clinicopathologic and biologic factors in neuroblastomas.
Dungwa JV; Hunt LP; Ramani P
Hum Pathol; 2012 Oct; 43(10):1651-60. PubMed ID: 22436629
[TBL] [Abstract][Full Text] [Related]
14. An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers.
Le QT; Chen E; Salim A; Cao H; Kong CS; Whyte R; Donington J; Cannon W; Wakelee H; Tibshirani R; Mitchell JD; Richardson D; O'Byrne KJ; Koong AC; Giaccia AJ
Clin Cancer Res; 2006 Mar; 12(5):1507-14. PubMed ID: 16533775
[TBL] [Abstract][Full Text] [Related]
15. Carbonic anhydrase IX is a predictive marker of doxorubicin resistance in early-stage breast cancer independent of HER2 and TOP2A amplification.
Betof AS; Rabbani ZN; Hardee ME; Kim SJ; Broadwater G; Bentley RC; Snyder SA; Vujaskovic Z; Oosterwijk E; Harris LN; Horton JK; Dewhirst MW; Blackwell KL
Br J Cancer; 2012 Feb; 106(5):916-22. PubMed ID: 22333602
[TBL] [Abstract][Full Text] [Related]
16. Carbonic Anhydrase IX is not a predictor of outcomes in non-metastatic clear cell renal cell carcinoma - a digital analysis of tissue microarray.
Zerati M; Leite KR; Pontes-Junior J; Segre CC; Reis ST; Srougi M; Dall'Oglio MF
Int Braz J Urol; 2013; 39(4):484-92. PubMed ID: 24054396
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of carbonic anhydrase IX (CA-IX), endoglin (CD105) and 8-hydroxy-2'-deoxyguanosine (8-OHdG) in breast cancer patients.
Beketic-Oreskovic L; Ozretic P; Rabbani ZN; Jackson IL; Sarcevic B; Levanat S; Maric P; Babic I; Vujaskovic Z
Pathol Oncol Res; 2011 Sep; 17(3):593-603. PubMed ID: 21249485
[TBL] [Abstract][Full Text] [Related]
18. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
19. Carbonic anhydrase IX and response to postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of the DBCG82 b and c trials.
Kyndi M; Sørensen FB; Knudsen H; Alsner J; Overgaard M; Nielsen HM; Overgaard J;
Breast Cancer Res; 2008; 10(2):R24. PubMed ID: 18355402
[TBL] [Abstract][Full Text] [Related]
20. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
